期刊文献+

慢性乙型肝炎患者外周血Treg细胞对DC细胞的抑制作用 被引量:2

Immunosuppression effects of CD4^+CD25^+Treg cells on dendritic cells from patients with chronic hepatitis B
在线阅读 下载PDF
导出
摘要 目的检测慢性乙型肝炎患者外周血中Treg细胞的比例,并探讨其对DC细胞的免疫抑制作用。方法抽取慢性乙型肝炎(CHB)患者和正常对照组的外周血,流式细胞术检测CD4+CD25+Treg细胞的比例以及DC细胞表面CD80和人白细胞(位点)DR抗原(HLA-DR)的表达;在DC培养的不同时间内加入不同比例CHB患者的Treg细胞,检测DC对淋巴细胞增殖功能的影响;检测DC培养的不同时间内加入不同比例CHB患者的Treg细胞后培养上清中细胞因子白细胞介素-10(IL-10)和肿瘤转化因子-β(TGF-β)的表达。结果正常人外周血中Treg(CD4+CD25+Foxp3+)细胞的比例为(4.12±1.36)%,CHB患者外周血中Treg细胞的比例为(10.54±3.27)%,CHB患者外周血中的Treg细胞比例明显高于正常组,差异有统计学意义;CHB患者表面分子CD80的表达为(60.12±5.23)%,HLA-DR的表达为(61.21±4.28)%;而正常组的CD80的表达为(84.13±4.33)%,HLA-DR的表达为(86.57±3.82)%,CHB患者DC细胞表面分子CD80和HLA-DR的表达均显著低于正常组,差异有统计学意义;经Treg细胞处理后,DC细胞刺激淋巴细胞的增殖能力下降,淋巴细胞增殖的抑制率较正常组均显著升高;Treg细胞与DC细胞比例为1∶1、1∶10以及1∶100时,IL-10和TGF-β的表达均显著高于正常组,并且随着Treg细胞的比例增高,细胞因子的水平也相应增高,差异有统计学意义。结论 CHB患者外周血中Treg细胞比例增高,可能是通过诱导IL-10和TGF-β的表达抑制DC细胞的免疫功能。 【Objective】To investigate the immunosuppressive effect of the regulatory T(Treg) cells on the dendritic cells in the pathogenesis of chronic hepatitis B(CHB).【Methods】Peripheral blood mononuclear cells(PBMC)were isolated from CHB patients and normal people, and flow cytometry were used to detect the frequency of CD4^+CD25^+Treg cells and the expression of CD80 and HLA-DR on the surface of dendritic cells(DCs); Treg cells from CHB group and DCs from normal group were cocultured under different ratio and time, and the suppressing index was detected; coculture supernatant concentrations of interleukin-10(IL-10) and tumor transforming factor-β(TGF-β) were detected by enzyme linked immunosorbent assay(ELISA). 【Results】The frequency of Treg cells in CHB group was(10.54 ± 3.27)%, and its frequency in normal group was(4.12 ± 1.36)%, and the difference had statistical significance; the expression of CD80 on the surface of DCs from CHB group was(60.12 ± 5.23)%, while the expression of HLA-DR on the surface of DCs from CHB group was(61.21 ± 4.28)%; the expression of CD80 in normal group was(84.13 ± 4.33)%, while the expression of HLA-DR in normal group was(86.57 ± 3.82)%; the expression of CD80 and HLA-DR on the surface of DCs in CHB patients was significant lower than that in normal group; CD4^+CD25^+Treg cells from CHB group had significant suppressing effects on the immune function of DCs which showed time and dose dependence; the secretion of IL-10 and TGF-β increased significantly in CHB group.【Conclusions】The increasing proportion of Treg cells in peripheral blood of patients with CHB may suppressing the immune function of DCs by inducing IL-10 and TGF-β expression.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第13期24-29,共6页 China Journal of Modern Medicine
基金 河南省院科技合作项目(No:092106000032)
关键词 慢性乙型肝炎 TREG细胞 DC细胞 白细胞介素-10 肿瘤转化因子-β chronic hepatitis B CD4^+CD25^+Treg cells dendritic cells interleukin-10 (IL-10) tumor transform- ing factor-β (TGF-β)
  • 相关文献

参考文献20

  • 1SARVARI J, MOJTAHEDI Z, KURAMITSU Y, et al. Differential expression of haptoglobin isoforms in chronic active hepatitis, cir- rhosis and HCC related to HBV infection[J]. Oncology Letters, 2011, 2(5): 871-877.
  • 2PATRA UC. An open label prospective observational study to e- valuate the efficacy of entecavir in HBeAg positive treatment naive chronic hepatitis B patients in a tertiary care center in eastern India[J]. Trop Gastroenterol, 2011, 32(4): 314-316.
  • 3ROMANI S, AZIMZADEH P, MOHEBBI SR, et al. Investigation of transforming growth faetor-betal gene polymorphisms among i- ranian patients with chronic hepatitis C[J]. Hepat Mon, 2011, 11 (11): 901-906.
  • 4MORISHIMA C, DI BISCEGLIE AM, ROTHMAN AL, et al. Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C[J]. J Viral Hepat, 2012, 19(6): 404-413.
  • 5魏来.慢性丙型肝炎病毒感染的治疗:热点、难点和希望[J].中华内科杂志,2011,50(12):993-994. 被引量:1
  • 6于建武,孙丽杰,康鹏,赵勇华,颜炳柱,朱鹏飞.年龄及性别因素对慢性丙型肝炎患者聚乙二醇干扰素α-2a联合利巴韦林抗病毒疗效的影响[J].中华内科杂志,2011,50(12):1002-1007. 被引量:6
  • 7陈莉,李聪智,孟秀娟,朱平安,谭德明.慢性乙型肝炎患者DC-SIGN启动区变异分析(英文)[J].中南大学学报(医学版),2011,36(11):1052-1058. 被引量:3
  • 8ZHANG Z, CHEN D, YAO J, et al. Increased infiltration of in- trahepatie DC subsets closely correlate with viral control and liv- er injury in immune active pediatric patients with chronic hep- atitis B[J]. Clin Immunol, 2007, 122(2): 173-180.
  • 9YU XP, GUO RY, SU ML, et al. Dynamic changes of Treg and Thl7 cells and related cytokines closely correlate with the vire- logical and biochemical response in chronic hepatitis b patients undergoing nueleos(t)ide analogues treatment[J]. Hepat Man, 2013, 13(12): e15332.
  • 10SU Z J, YU XP, GUO RY, et al. Changes in the balance be- tween Treg and Thl7 cells in patients with chronic hepatitis B [J]. Diagn Microbiol Infect Dis, 2013, 76(4): 437-444.

二级参考文献25

  • 1丙型肝炎防治指南[J].中华内科杂志,2004,43(7):551-555. 被引量:106
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 3C Nú■ez,B Rueda,A Martínez,C Maluenda,I Polanco,MA López-Nevot,E Ortega,E Sierra,E Gómez de la Concha,E Urcelay,J Martín.A functional variant in the CD209 promoter is associated with DQ2-negative celiac disease in the Spanish population[J].World Journal of Gastroenterology,2006,12(27):4397-4400. 被引量:1
  • 4Asselah T.Realize the advance in HCV treatment,but remain cautious[J/OL].J Hepatol,2011[2011-09-26].http://www.sciencedirect.com/science/article/pii/S0168827811006143.[Epub ahead of print].
  • 5European Association for the Study of the Liver.EASL Clinical Practice Guidelines:management of hepatitis C virus infection.J Hepatol,2011,55:245-264.
  • 6Trépo E,Pradat P,Potthoff A,et al.Impact of patatin-like phospholipase-3 (rs738409 C > G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.Hepatology,2011,54:60-69.
  • 7Sarrazin C,Kieffer TL,Bartels D,et al.Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.Gastroenterology,2007,132:1767-1777.
  • 8Jacobson IM,McHutchison JG,Dusheiko G,et al.Telaprevir for previously untreated chronic hepatitis C virus infection.N Engl J Med,2011,364:2405-2416.
  • 9Poordad F,McCone J Jr,Bacon BR,et al.Boceprevir for untreated chronic HCV genotype 1 infection.N Engl J Med,2011,364:1195-1206.
  • 10Zeuzem S,Andreone P,Pol S,et al.Telaprevir for retreatment of HCV infection.N Engl J Med,2011,364:2417-2428.

共引文献7

同被引文献25

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部